VKH
EBS icon

Virtu KCG Holdings’s Emergent Biosolutions EBS Stock Holding History

Virtu KCG Holdings’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-6,426
Closed -$211K – 3247
2016
Q4 		$211K Buy
+6,426
New +$193K 0.01% 2523
2016
Q3 		– Sell
-33,792
Closed -$950K – 3139
2016
Q2 		$950K Buy
+33,792
New +$1.32M 0.02% 795
2016
Q1 		– Sell
-7,749
Closed -$310K – 2992
2015
Q4 		$310K Buy
+7,749
New +$270K 0.01% 2109
2014
Q2 		– Sell
-14,491
Closed -$366K – 3740
2014
Q1 		$366K Buy
+14,491
New +$366K ﹤0.01% 2306

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
AAM
Aberdeen Asset Management Aberdeen, United Kingdom $30B AUM 22.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Virtu KCG Holdings's EBS Position: Q1 2017 in Review

Virtu KCG Holdings sold out of Emergent Biosolutions (EBS) in Q1 2017, closing a stake of 6,426 shares — an estimated $211K sold.

Virtu KCG Holdings first reported a position in EBS in Q1 2014 and held it in 4 quarters. The position peaked at $950K in Q2 2016. 176 funds tracked by Wall St. Rank hold EBS as of Q1 2017.

  • Virtu KCG Holdings reported no remaining Emergent Biosolutions position as of Q1 2017 after selling out during the quarter.
  • Virtu KCG Holdings sold 6,426 Emergent Biosolutions shares in Q1 2017, an estimated $211K.
  • Virtu KCG Holdings first reported a position in Emergent Biosolutions in Q1 2014 and held it in 4 quarters.
  • Virtu KCG Holdings's Emergent Biosolutions position peaked at $950K in Q2 2016.
  • 176 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2017.

Based on Virtu KCG Holdings's 13F filing for Q1 2017, filed 12 May 2017.